Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/86373

Beta release

Statistics of MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
Statistics for this year
PeriodVisitsDownloads
20244844
Statistics for the last 3 months
PeriodVisitsDownloads
2024-07108
2024-0844
2024-0922